Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 219
Filter
1.
Dis Colon Rectum ; 65(3): 413-420, 2022 03 01.
Article in English | MEDLINE | ID: mdl-33872283

ABSTRACT

BACKGROUND: Low anterior resection syndrome has a negative impact on quality of life. Intestinal irrigation is a method of lavage consisting of a scheduled evacuation. OBJECTIVE: This study aims to evaluate functional and quality-of-life outcomes in patients with low anterior resection syndrome after transanal irrigation using a colostomy irrigation system. DESIGN: This was a prospective case series. SETTINGS: This study presents a single-center experience at a tertiary oncological center in an upper-middle-income country. PATIENTS: Patients classified as having minor or major low anterior resection syndrome 12 months after their operation were selected. INTERVENTIONS: Transanal irrigation was performed using an ostomy irrigation kit. Questionnaires assessing patients' bowel function (low anterior resection syndrome and Wexner score) and quality of life (Short Form-36 questionnaire) were applied before and after treatment. MAIN OUTCOME MEASURES: The primary outcomes were low anterior resection syndrome score and quality-of-life improvement after a 12-month treatment. RESULTS: Of the 22 patients included, 20 had major and 2 had minor low anterior resection syndrome, with a median score of 39, especially high rates of incontinence for liquid stool (21; 95.5%), clustering (21; 95.5%), and urgency (17; 77.3%). All patients successfully completed the 3-day training, and there were no complications during the treatment. After the 12-month period, the median score was 8, with 90% of the patients classified as having "no syndrome" and great improvement in all domains of this score. The most improved quality-of-life sections were patient vitality (p = 0.025) and physical (p = 0.002), social (p = 0.001), and emotional aspects (p = 0.001). LIMITATIONS: The study was limited by its small sample size and the limited follow-up period. CONCLUSIONS: This study presents a safe implementation protocol of an ostomy irrigation device for transanal irrigation. It also adds to the literature that transanal irrigation is a safe, effective, and easily implemented procedure for patients with low anterior resection syndrome with a significant improvement in quality of life. See Video Abstract at http://links.lww.com/DCR/B563.ESTUDIO DE FACTIBILIDAD DE LA IRRIGACIÓN TRANSANAL UTILIZANDO EL SISTEMA DE IRRIGACIÓN PARA COLOSTOMÍA EN PACIENTES CON SÍNDROME DE RESECCIÓN ANTERIOR BAJAANTECEDENTES:El síndrome de resección anterior baja tiene un impacto negativo en la calidad de vida de los pacientes. La irrigación intestinal es un método de lavado que consiste en evacuaciones programadas.OBJETIVOS:Evaluar los resultados de la funcionalidad e impacto en la calidad de vida de los pacientes con síndrome de resección anterior y baja posterior a la irrigación transanal utilizando un sistema de irrigación de colostomía.DISEÑO:Es estudio prospectivo de una serie de casos.ESCENARIO:En este estudio se muestra la experiencia de un centro oncológico de tercer nivel en un país en vías de desarrollo.PACIENTES:Aquellos clasificados como síndrome con afección en menor o mayor grado doce meses después de la cirugía.METODO:Se efectuó irrigación transanal utilizando un equipo de irrigación de estomas. Se aplicaron cuestionarios para valorar la función intestinal de los pacientes (síndrome de resección anterior baja y la escala de Wexner) y para calidad de vida (Cuestionario Corto-36) antes y después del tratamiento.EVALUACION DE LOS RESULTADOS PRINCIPALES:Los principales resultados se obtuvieron de la escala del síndrome de resección baja y la mejoría en la calidad vida doce meses después de tratamiento.RESULTADOS:De los veintidós pacientes incluidos, veinte presentaron manifestaciones mayores del síndrome de resección baja y dos, manifestaciones menores. Con una media de treinta y nueve, se encontraron, especialmente, altos índices de incontinencia a líquidos (21; 95'5%) hiperdefecación "clustering" (21; 95'5%) y urgencia (17; 77'3%). Todos los pacientes completaron en forma satisfactoria el entrenamiento de tres días sin presentarse complicaciones durante el tratamiento. Al término del mes doce la media fue de ocho, con el 90% de los pacientes clasificados como "sin síndrome" y se observó una mejoría substancial en todos los puntos de la evaluación. Las secciones de calidad de vida que mostraron una mejoría significativa fueron: la vitalidad del paciente (p = 0'025), física (p = 0'002), social (p = 0'001) y emocional (p = 0'001).LIMITACIONES:El tamaño de la muestra es pequeño y el tiempo de seguimiento corto.CONCLUSIONES:Este estudio muestra la implementación de un protocolo seguro para la irrigación de estomas mediante un dispositivo transanal. Además contribuye con el concepto en la literatura de que la seguridad de la irrigación transanal es seguro, efectivo y facilmente reproducible para pacientes con síndrome de resección anterior baja con una mejoría significativa en la calidad de vida. Consulte Video Resumen en http://links.lww.com/DCR/B563. (Traducción-Dr. Miguel Esquivel-Herrera).


Subject(s)
Catheters , Intestine, Large/physiopathology , Postoperative Complications , Proctectomy/adverse effects , Quality of Life , Rectal Diseases , Rectal Neoplasms/surgery , Therapeutic Irrigation , Anastomosis, Surgical/adverse effects , Anastomosis, Surgical/methods , Equipment Design , Female , Humans , Male , Middle Aged , Neoadjuvant Therapy/methods , Neoadjuvant Therapy/statistics & numerical data , Postoperative Complications/etiology , Postoperative Complications/physiopathology , Postoperative Complications/psychology , Postoperative Complications/therapy , Proctectomy/methods , Rectal Diseases/etiology , Rectal Diseases/physiopathology , Rectal Diseases/psychology , Rectal Diseases/therapy , Rectal Neoplasms/drug therapy , Rectal Neoplasms/radiotherapy , Retrospective Studies , Therapeutic Irrigation/instrumentation , Therapeutic Irrigation/methods , Treatment Outcome
2.
Nutrients ; 13(4)2021 Apr 11.
Article in English | MEDLINE | ID: mdl-33920345

ABSTRACT

Numerous disorders can alter the physiological mechanisms that guarantee proper digestion and absorption of nutrients (macro- and micronutrients), leading to a wide variety of symptoms and nutritional consequences. Malabsorption can be caused by many diseases of the small intestine, as well as by diseases of the pancreas, liver, biliary tract, and stomach. This article provides an overview of pathophysiologic mechanisms that lead to symptoms or complications of maldigestion (defined as the defective intraluminal hydrolysis of nutrients) or malabsorption (defined as defective mucosal absorption), as well as its clinical consequences, including both gastrointestinal symptoms and extraintestinal manifestations and/or laboratory abnormalities. The normal uptake of nutrients, vitamins, and minerals by the gastrointestinal tract (GI) requires several steps, each of which can be compromised in disease. This article will first describe the mechanisms that lead to poor assimilation of nutrients, and secondly discuss the symptoms and nutritional consequences of each specific disorder. The clinician must be aware that many malabsorptive disorders are manifested by subtle disorders, even without gastrointestinal symptoms (for example, anemia, osteoporosis, or infertility in celiac disease), so the index of suspicion must be high to recognize the underlying diseases in time.


Subject(s)
Intestinal Mucosa/physiopathology , Intestine, Large/physiopathology , Intestine, Small/physiopathology , Malabsorption Syndromes/physiopathology , Nutrients/metabolism , Anemia/diagnosis , Anemia/etiology , Anemia/prevention & control , Humans , Infertility/diagnosis , Infertility/etiology , Infertility/prevention & control , Intestinal Absorption/physiology , Intestinal Mucosa/diagnostic imaging , Intestine, Large/diagnostic imaging , Intestine, Small/diagnostic imaging , Malabsorption Syndromes/complications , Malabsorption Syndromes/diagnosis , Malabsorption Syndromes/therapy , Osteoporosis/diagnosis , Osteoporosis/etiology , Osteoporosis/prevention & control
3.
Eur J Pediatr Surg ; 31(1): 40-48, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32877942

ABSTRACT

INTRODUCTION: The objective of this study is to determine short-term complications and evaluate long-term bowel function, lower urinary tract symptoms, and quality of life (QoL) in patients treated for Hirschsprung's disease (HSCR) with transanal endorectal pull-though (TERPT) compared with healthy controls. MATERIALS AND METHODS: This cross-sectional case-control study included 30 HSCR patients treated with TERPT in 2006 to 2014 at Karolinska University Hospital, and 30 healthy controls matched for age and gender. Data on short-term complications were compiled from medical records and classified according to Clavien-Dindo. Bowel function and QoL were evaluated with the validated questionnaires bowel function score and KIDSCREEN-52. Lower urinary tract symptoms were evaluated through an 8-item lower urinary tract symptoms (LUTS) questionnaire. RESULTS: Six (20%) patients had a short-term postoperative complication according to Clavien-Dindo, with insufficient pain management being the most common complication. The median age at follow-up was 7 years (range = 4-11). Median bowel function score was significantly lower in HSCR patients than in controls, 14 versus 19 (p < 0.001). Twenty-one of the HSCR patients reported impaired bowel function compared with two of the controls (p < 0.001). The overall prevalence of LUTS was 11 (38%) in the HSCR patients compared with seven (23%) in the controls (p = 0.751). HSCR patients reported a slightly lower QoL in the KIDSCREEN domain "financial resources" compared with controls (p = 0.008). CONCLUSION: According to Clavien-Dindo, short-term postoperative complications occurred in 20% of the patients. Impaired bowel function persists throughout childhood for most HSCR patients. The prevalence of LUTS and QoL is not affected in HSCR patients compared with controls.


Subject(s)
Hirschsprung Disease/surgery , Intestine, Large/physiopathology , Lower Urinary Tract Symptoms/epidemiology , Quality of Life , Case-Control Studies , Child , Child, Preschool , Cross-Sectional Studies , Female , Hirschsprung Disease/rehabilitation , Humans , Male , Postoperative Complications/epidemiology , Surveys and Questionnaires , Treatment Outcome
4.
Neuromodulation ; 23(8): 1082-1093, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32830414

ABSTRACT

OBJECTIVE: Sacral neuromodulation (SNM) has been used to treat patients with lower urinary tract dysfunction and bowel dysfunction for many years. Success rates vary between 50% and 80%, indicating that there is much room for improvement. Altering stimulation parameters may result in improved outcome. This paper reports a systematic review of the clinical efficacy of nonconventional stimulation parameters on urinary tract and bowel dysfunction. MATERIALS AND METHODS: Three databases were used for the literature search: Ovid (Medline, Embase) and PubMed. Papers were screened by two independent reviewers, who also extracted data from these papers. Clinical papers studying SNM stimulation parameters, that is, intermittent stimulation, frequency, pulse width, and amplitude, in urinary tract and bowel dysfunction were included. Quality of included papers was assessed using standardized guidelines. RESULTS: Out of 5659 screened papers, 17 papers, studying various stimulation parameters, were included. Overall quality of these papers differed greatly, as some showed no risk of bias, whereas others showed high risk of bias. Stimulation parameters included intermittent stimulation, frequency, pulse width, amplitude, and unilateral vs. bilateral stimulation. Especially high frequency SNM and either a narrow or wide pulse width seem to improve efficacy in patients with bowel dysfunction. Additionally, implementation of short cycling intervals is promising to improve quality of life for patients with urinary tract or bowel dysfunction. CONCLUSION: The results of our systematic review indicate that stimulation parameters may improve efficacy of SNM in treatment of both urinary tract dysfunction and bowel dysfunction.


Subject(s)
Electric Stimulation Therapy , Intestinal Diseases , Intestine, Large , Urinary Tract , Urologic Diseases , Humans , Intestinal Diseases/therapy , Intestine, Large/physiopathology , Lumbosacral Plexus , Quality of Life , Treatment Outcome , Urinary Bladder , Urinary Tract/physiopathology , Urologic Diseases/therapy
5.
Neuromodulation ; 23(8): 1094-1107, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32809262

ABSTRACT

OBJECTIVE: Conventional sacral neuromodulation (SNM) has shown to be an effective treatment for lower urinary tract and bowel dysfunction, but improvements of clinical outcome are still feasible. Currently, in preclinical research, new stimulation parameters are being investigated to achieve better and longer effects. This systematic review summarizes the status of SNM stimulation parameters and its effect on urinary tract and bowel dysfunction in preclinical research. MATERIALS AND METHODS: The literature search was conducted using three databases: Ovid (Medline, Embase) and PubMed. Articles were included if they reported on stimulation parameters in animal studies for lower urinary tract or bowel dysfunction as a primary outcome. Methodological quality assessment was performed using the SYRCLE Risk of Bias (RoB) tool for animal studies. RESULTS: Twenty-two articles were eligible for this systematic review and various aspects of stimulation parameters were included: frequency, intensity, pulse width, stimulation signal, timing of stimulation, and unilateral vs. bilateral stimulation. In general, all experimental studies reported an acute effect of SNM on urinary tract or bowel dysfunction, whereas at the same time, various stimulation settings were used. CONCLUSIONS: The results of this systematic review indicate that SNM has a positive therapeutic effect on lower urinary tract and bowel dysfunction. Using low-frequency-SNM, high-frequency-SNM, bilateral SNM, and higher pulse widths showed beneficial effects on storage and evacuation dysfunction in animal studies. An increased variability of stimulation parameters may serve as a basis for future improvement of the effect of SNM in patients suffering from urinary tract or bowel dysfunction.


Subject(s)
Electric Stimulation Therapy , Intestinal Diseases/therapy , Intestine, Large/physiopathology , Urinary Tract , Urologic Diseases/therapy , Animals , Female , Humans , Lumbosacral Plexus , Male , Sacrum , Treatment Outcome , Urinary Bladder , Urinary Tract/physiopathology
6.
Acta Oncol ; 59(10): 1186-1192, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32500780

ABSTRACT

PURPOSE: Pelvic target dose from intensity-modulated proton therapy (IMPT) is sensitive to patient bowel motion. Robustly optimized plans in regard to bowel filling may improve the dose coverage in the treatment course. Our purpose is to investigate the effect of air volume in large and small bowel and rectum on target dose from IMPT plans. METHODS AND MATERIAL: Data from 17 cancer patients (11 prostate, 3 gynecologic, 2 colon, and 1 embryonal rhabdomyosarcoma) with planning CT (pCT) and weekly or biweekly scanned quality assurance CTs (QACTs; 82 QACT scans total) were studied. Air in bowels and rectum traversed by proton pencil beams was contoured. The robust treatment plan was made by using 3 CT sets: the pCT set and 2 virtual CT sets that were copies of pCT but in which the fillings of bowels and rectum were overridden to be either air or muscle. Each plan had 2-5 beams with a mean of 3 beams. Targets in the pCT were mapped to the QACTs by deformable image registration, and the dose in QACTs was calculated. Dose coverage (D99 and D95) and correlations between dose coverage and changes in air volume were analyzed. The significance of the correlation was analyzed by t test. RESULTS: Mean changes of D99 in QACTs were within 3% of those in the pCT for all prostate and colon cases but >3% in 2 of the 3 gynecologic cases and in the embryonal rhabdomyosarcoma case. Of these three cases with mean change of D99 > 3%, air volume may be the main cause in 2. For the prostate cases, correlation coefficients were <0.7 between change in air volume and change in D99 and D95, because other anatomy changes also contributed to dose deviation. Correlation coefficients in the non-prostate cases were >0.9 between D99 change and rectum and between D95 change and small bowel, indicating a greater effect of the air volume on target dose. CONCLUSION: The air volume may still have an important effect on target dose coverage in treatment plans using 3 CT sets, particularly when the air is traversed by multiple beams.


Subject(s)
Air , Intestine, Large/physiopathology , Neoplasms/radiotherapy , Proton Therapy , Radiotherapy, Intensity-Modulated , Rectum/physiopathology , Humans , Organs at Risk , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted
8.
Clin Anat ; 33(8): 1181-1186, 2020 Nov.
Article in English | MEDLINE | ID: mdl-31960980

ABSTRACT

Clinical management of constipation has evolved from the prescription of dietary supplements, to potent stimulant laxatives, to corrective surgeries for organic blockage. Yet constipation does not respond to a one-size-fits-all treatment. In recent decades, the Bristol Stool Form Scale and Rome III diagnostic criteria have allowed for algorithmic diagnosis, yet these criteria could benefit from further extension and meaningful discussion. This review incorporates pertinent clinical updates and uses the anatomy and physiology of constipation as helpful signposts for the practicing clinician.


Subject(s)
Constipation/etiology , Intestine, Large/anatomy & histology , Constipation/diagnosis , Constipation/physiopathology , Constipation/therapy , Defecation , Humans , Intestine, Large/physiopathology
9.
Female Pelvic Med Reconstr Surg ; 26(2): 137-140, 2020 02.
Article in English | MEDLINE | ID: mdl-31990802

ABSTRACT

OBJECTIVE: The primary aim of this study was to determine if fecal incontinence (FI) is associated with self-reported fluid intake in women seeking care for pelvic floor disorders. The secondary aim was to determine the association between bowel symptoms and fluids associated with FI. METHODS: We conducted a retrospective cross-sectional study of women presenting for evaluation of pelvic floor disorders from 2009 to 2015. The presence of FI was defined as an affirmative response of any frequency to the question, "During the last 4 weeks, how often have you leaked or soiled yourself with stool?" Data on fluid intake and bowel symptoms were collected using the Questionnaire-based Voiding Diary and Colorectal-Anal Distress Inventory short form, respectively. The relationship between FI and quartiles of fluid intake, as well as the relationship between bowel symptoms and fluids associated with FI, was analyzed. RESULTS: Nine hundred twenty-four women were included: 379 (41%) with and 545 (59%) without FI. There was an association between FI and increasing total carbonated fluid intake (P = 0.009) and decreasing water intake (P = 0.009). The associations between FI and carbonated fluid intake and FI and water intake remained significant after controlling for patient characteristics (P < 0.05). There was a significant association between the symptom of straining to defecate and carbonated beverage intake (P = 0.046), which remained significant after controlling for patient characteristics (P < 0.001). CONCLUSIONS: Consumption of carbonated beverages is associated with FI in women. Intake of carbonated fluids is associated with bowel symptoms that may exacerbate FI symptoms.


Subject(s)
Carbonated Water/adverse effects , Drinking/physiology , Fecal Incontinence , Intestine, Large/physiopathology , Pelvic Floor Disorders , Cross-Sectional Studies , Fecal Incontinence/diagnosis , Fecal Incontinence/epidemiology , Fecal Incontinence/etiology , Female , Gastrointestinal Motility , Humans , Middle Aged , Pelvic Floor/physiopathology , Pelvic Floor Disorders/diagnosis , Pelvic Floor Disorders/epidemiology , Pelvic Floor Disorders/physiopathology , Qualitative Research , Retrospective Studies , Surveys and Questionnaires
10.
Int J Mol Sci ; 20(21)2019 Oct 26.
Article in English | MEDLINE | ID: mdl-31717769

ABSTRACT

Inflammatory bowel disease (IBD) is a multifactorial human intestinal disease that arises from numerous, yet incompletely defined, factors. Two main forms, Crohn's disease (CD) and ulcerative colitis (UC), lead to a chronic pathological form. Heat shock proteins (HSPs) are stress-responsive molecules involved in various pathophysiological processes. Several lines of evidence link the expression of HSPs to the development and prognosis of IBD. HSP90, HSP70 and HSP60 have been reported to contribute to IBD in different aspects. Moreover, induction and/or targeted inhibition of specific HSPs have been suggested to ameliorate the disease consequences. In the present review, we shed the light on the role of HSPs in IBD and their targeting to prevent further disease progression.


Subject(s)
Colitis, Ulcerative/metabolism , Crohn Disease/metabolism , HSP70 Heat-Shock Proteins/metabolism , HSP90 Heat-Shock Proteins/metabolism , Intestine, Large/metabolism , Chaperonin 60/metabolism , Colitis, Ulcerative/complications , Colitis, Ulcerative/drug therapy , Colitis, Ulcerative/immunology , Crohn Disease/complications , Crohn Disease/drug therapy , Crohn Disease/immunology , Disease Progression , Heat-Shock Proteins/antagonists & inhibitors , Heat-Shock Proteins, Small/metabolism , Humans , Intestinal Neoplasms/etiology , Intestinal Neoplasms/metabolism , Intestine, Large/immunology , Intestine, Large/physiopathology , Mitochondrial Proteins/metabolism , Prognosis
11.
J Gastrointest Surg ; 23(4): 800-807, 2019 04.
Article in English | MEDLINE | ID: mdl-30350191

ABSTRACT

BACKGROUND: Neoadjuvant chemoradiation (CRT) impairs bowel function in patients with rectal cancer treated with total mesorectal excision (TME). The impact of other forms of neoadjuvant therapy such as neoadjuvant chemotherapy alone (NC) and induction chemotherapy followed by CRT (total neoadjuvant therapy or TNT) on postoperative bowel function has not been investigated. METHODS: We conducted a retrospective review of 176 rectal cancer patients treated between November 1, 2011, and August 31, 2017. All patients completed the MSKCC Bowel Function Instrument (BFI), a validated bowel function questionnaire, at least 6 months after TME and/or ileostomy reversal. Differences in BFI scores were compared across four groups (surgery alone, CRT, NC, and TNT) and also according to exposure to neoadjuvant RT and neoadjuvant chemotherapy. A multivariable linear regression model was used to evaluate the independent relationship between exposure to neoadjuvant RT or chemotherapy and BFI. RESULTS: BFI total scores were significantly different between the four groups (p = 0.008). Exposure to RT correlated with worse BFI total scores (p = 0.002), and no differences were found in BFI total score after exposure to neoadjuvant chemotherapy (p = 0.92). In a linear regression model, only exposure to RT (ß = - 5.1; 95% CI - 8.9 to - 1.3; p = 0.008) and tumor distance from the anal verge (ß = 1.23; 95% CI 0.48 to 1.97; p = 0.001) were significantly correlated with BFI total score. CONCLUSION: NC, whether administered alone or added to CRT, does not seem to impair bowel function. These data should be used to counsel rectal cancer patients when discussing neoadjuvant therapy options.


Subject(s)
Intestine, Large/physiopathology , Neoadjuvant Therapy , Rectal Neoplasms/therapy , Adult , Aged , Chemoradiotherapy, Adjuvant/adverse effects , Chemotherapy, Adjuvant/adverse effects , Female , Humans , Induction Chemotherapy/adverse effects , Male , Middle Aged , Neoadjuvant Therapy/adverse effects , Neoadjuvant Therapy/methods , Rectal Neoplasms/pathology , Rectal Neoplasms/surgery , Retrospective Studies , Surveys and Questionnaires
12.
J Pediatr Gastroenterol Nutr ; 66(4): e89-e98, 2018 04.
Article in English | MEDLINE | ID: mdl-29287015

ABSTRACT

Constipation is one of the most common gastrointestinal symptoms in children. With a median reported prevalence of 12%, it accounts for about 25% of all pediatric gastroenterology consultations. The majority of children experiences functional constipation and do not usually require any diagnostic testing. For those children not responding to conventional medical treatment or in the presence of a more significant clinical picture, however, an accurate instrumental assessment is usually recommended to evaluate either the underlying pathophysiologic mechanisms or a possible organic etiology. The present review analyzes the possible diagnostic investigations for severely constipated children, focusing on their actual indications and their utility in clinical practice. During the last decade, there has been a remarkable increase in our knowledge of normal and abnormal colonic and anorectal motility in children, and a number of different techniques to measure transit and motility have been developed and are discussed in this narrative review.


Subject(s)
Constipation/diagnosis , Diagnostic Techniques, Digestive System , Intestine, Large/physiopathology , Child , Child, Preschool , Gastrointestinal Motility , Humans , Magnetic Resonance Imaging/methods , Manometry/methods , Radionuclide Imaging/methods
13.
World J Gastroenterol ; 23(23): 4135-4139, 2017 Jun 21.
Article in English | MEDLINE | ID: mdl-28694653

ABSTRACT

Attenuated adenomatous polyposis (AAP) is a poorly understood syndrome, that can be defined as the presence of 10-99 synchronous adenomas in the large bowel, and it is considered a phenotypic variant of familial adenomatous polyposis (FAP). This definition has the advantage of simplicity, but it may include sporadic multiple adenomas of the large bowel at an extreme, or FAP cases on the other side. AAP shows a milder phenotype than FAP, with an older age of onset of adenomas and cancer, and less frequent extracolonic manifestations. AAP may be diagnosed as a single case in a family or, less frequently, it may be present in other family members, and it shows distinct pattern of inheritance. In less than 50% of cases, it may be caused by adenomatous polyposis coli (APC) or MUTYH mutations, referred to as APC-associated polyposis, inherited as an autosomal dominant trait, or MUTYH-associated polyposis, which shows an autosomal recessive mechanism of inheritance, respectively. Surveillance should rely on colonoscopy at regular intervals, with removal of adenomas and careful histological examination. When removal of polyps is not possible or advanced lesions are observed, the surgical approach is mandatory, being subtotal colectomy with ileo-rectal anastomosis the treatment of choice. Studies on this syndrome are lacking, and controversies are still present on many issues, thus, other clinical and genetic studies are requested.


Subject(s)
Adenomatous Polyposis Coli/diagnosis , Adenomatous Polyposis Coli/therapy , Intestine, Large/physiopathology , Adenoma/diagnostic imaging , Adenoma/genetics , Adenoma/therapy , Adenomatous Polyposis Coli/genetics , Adenomatous Polyposis Coli Protein/genetics , Adenomatous Polyposis Coli Protein/metabolism , Age of Onset , Colonoscopy , DNA Glycosylases/genetics , DNA Glycosylases/metabolism , Gardner Syndrome/diagnostic imaging , Gardner Syndrome/genetics , Gardner Syndrome/therapy , Humans , Mutation , Neoplasms/diagnostic imaging , Neoplasms/genetics , Neoplasms/therapy , Phenotype , Treatment Outcome
14.
Tech Coloproctol ; 20(8): 559-66, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27262309

ABSTRACT

BACKGROUND: The aim of this study was to compare the outcome of an enhanced recovery after surgery (ERAS) pathway with traditional perioperative care in laparoscopic rectal resection. METHODS: A retrospective analysis of prospectively collected data was conducted. Single-center consecutive patients who underwent laparoscopic rectal surgery after an ERAS program were compared with patients who received traditional care over an 8-year period. Primary and total length of stay, and readmission, morbidity and mortality rates were analyzed. For ERAS group, the actual adherence to protocol was also evaluated. RESULTS: Two hundred and ninety-seven patients, 162 in the ERAS group and 135 in conventional care, were studied. Median primary and total length of stay were significantly shorter in the ERAS group (9 vs 12 days; p = 0.0001; 10 vs 12 days; p = 0.01; respectively). The ERAS group experienced a faster recovery of bowel function than the traditional care group (p = 0.0001). A similar morbidity rate was observed in the two groups (32.3 % in ERAS vs 36.1 % in traditional care p = 0.41). Readmission rates were 4.9 % in the ERAS versus 1.5 % in the traditional care group (p = 0.19). There was no mortality in either group. Overall mean compliance with the ERAS protocol was 85.7 % (range 54.4-100 %). CONCLUSIONS: The introduction of the ERAS protocol in laparoscopic rectal resection led to a reduction in primary and total length of hospital stay without an increase in morbidity or readmission rates when compared to traditional care.


Subject(s)
Early Ambulation , Laparoscopy/rehabilitation , Recovery of Function , Rectal Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Clinical Protocols , Female , Guideline Adherence , Humans , Intestine, Large/physiopathology , Laparoscopy/adverse effects , Length of Stay , Male , Middle Aged , Patient Readmission , Practice Guidelines as Topic , Retrospective Studies , Time Factors
15.
Tech Coloproctol ; 20(7): 445-53, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27137207

ABSTRACT

BACKGROUND: The aim of this study was to ascertain the impact of injury to the superior mesenteric nerve plexus caused by right colectomy with D3 extended mesenterectomy as performed in the prospective multicenter trial: "Safe Radical D3 Right Hemicolectomy for Cancer through Preoperative Biphasic Multi-detector Computed Tomography" in which all soft tissue surrounding the superior mesenteric vessels from the level of the middle colic artery to that of the ileocolic artery was removed. METHODS: Bowel function and gastrointestinal quality of life in two consecutive cohorts that underwent right colectomy with and without D3 extended mesenterectomy were compared. Main outcome measures were the Diarrhea Assessment Scale (DAS) and Gastrointestinal Quality of Life Index (GIQLI). The data were collected prospectively through telephone interviews. RESULTS: Forty-nine patients per group, comparable for age, sex, length of bowel resected but with significantly shorter follow-up time in the experimental group, were included. There was no difference in total DAS scores, subscores or additional questions except for higher bowel frequency scores in the D3 group (p = 0.02). Comparison of total GIQLI scores and subscales showed no difference between groups. Regression analysis with correction for confounding factors showed 0.48 lower bowel frequency scores in the D2 group (p = 0.022). Within the D3 group presence of jejunal arteries cranial to the D3 dissection area showed 1.78 lower DAS scores and 0.7 lower bowel frequency scores. CONCLUSIONS: Small bowel denervation after right colectomy with D3 extended mesenterectomy leads to increased bowel frequency but does not impact gastrointestinal quality of life. Individual anatomical variants can affect postoperative bowel function differently despite standardized surgery.


Subject(s)
Autonomic Pathways/injuries , Colectomy/methods , Colonic Neoplasms/surgery , Intestine, Large/physiopathology , Lymph Node Excision/methods , Mesentery/surgery , Quality of Life , Adult , Aged , Colectomy/adverse effects , Defecation , Diarrhea/etiology , Female , Humans , Intestine, Small/innervation , Male , Mesenteric Artery, Superior/anatomy & histology , Mesenteric Veins/anatomy & histology , Mesentery/anatomy & histology , Middle Aged , Postoperative Complications/etiology , Prospective Studies
16.
J Nutr ; 146(5): 949-56, 2016 05.
Article in English | MEDLINE | ID: mdl-27052535

ABSTRACT

BACKGROUND: Obesity is associated with compromised intestinal barrier function and shifts in gastrointestinal microbiota that may contribute to inflammation. Fiber provides benefits, but impacts of fiber type are not understood. OBJECTIVE: We aimed to determine the impact of cellulose compared with fructans on the fecal microbiota and gastrointestinal physiology in obese mice. METHODS: Eighteen-wk-old male diet-induced obese C57BL/6J mice (n = 6/group; 40.5 g) were fed high-fat diets (45% kcal fat) containing 5% cellulose (control), 10% cellulose, 10% short-chain fructooligosaccharides (scFOS), or 10% inulin for 4 wk. Cecal and colon tissues were collected to assess barrier function, histomorphology, and gene expression. Fecal DNA extracts were subjected to 16S ribosomal RNA amplicon-based Illumina MiSeq sequencing to assess microbiota. RESULTS: Body weight gain was greater (P < 0.05) in scFOS-fed than in 10% cellulose-fed mice. Both groups of fructan-fed mice had greater (P < 0.05) cecal crypt depth (scFOS: 141 µm; inulin: 145 µm) than both groups of cellulose-fed mice (5% and 10%: 109 µm). Inulin-fed mice had greater (P < 0.05) cecal transmural resistance (101 Ω × cm(2)) than 5% cellulose-fed controls (45 Ω × cm(2)). Inulin-fed mice had lower (P < 0.05) colonic mRNA abundance of Ocln (0.41) and Mct1 (0.35) than those fed 10% cellulose (Ocln: 1.28; Mct1: 0.90). Fructan and cellulose groups had different UniFrac distances of fecal microbiota (P < 0.05) and α diversity, which demonstrated lower (P < 0.01) species richness in fructan-fed mice. Mice fed scFOS had greater (P < 0.05) Actinobacteria (15.9%) and Verrucomicrobia (Akkermansia) (17.0%) than 5% controls (Actinobacteria: 0.07%; Akkermansia: 0.08%). Relative abundance of Akkermansia was positively correlated (r = 0.56, P < 0.01) with cecal crypt depth. CONCLUSIONS: Fructans markedly shifted gut microbiota and improved intestinal physiology in obese mice, but the mechanisms by which they affect gut integrity and inflammation in the obese are still unknown.


Subject(s)
Bacteria/drug effects , Dietary Fiber/pharmacology , Fructans/pharmacology , Gastrointestinal Microbiome/drug effects , Intestinal Mucosa/drug effects , Intestine, Large/drug effects , Obesity , Animals , Bacteria/genetics , Bacteria/growth & development , Cellulose/pharmacology , Diet, High-Fat , Feces/microbiology , Gene Expression , Inflammation/etiology , Intestinal Absorption , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Intestinal Mucosa/physiopathology , Intestine, Large/metabolism , Intestine, Large/pathology , Intestine, Large/physiopathology , Inulin/pharmacology , Male , Mice, Inbred C57BL , Mice, Obese , Monocarboxylic Acid Transporters/genetics , Monocarboxylic Acid Transporters/metabolism , Obesity/complications , Obesity/microbiology , Obesity/physiopathology , Occludin/genetics , Occludin/metabolism , Oligosaccharides/pharmacology , Oligosaccharides/therapeutic use , RNA, Messenger/metabolism , Symporters/genetics , Symporters/metabolism , Weight Gain/drug effects
17.
Rev. medica electron ; 37(6)nov.-dic., 2015. ilus
Article in Spanish | CUMED | ID: cum-63478

ABSTRACT

La melanosis coli consiste en una pigmentación negruzca de la mucosa del intestino grueso, producida por absorción de productos aromáticos, por uso excesivo de laxantes derivados del antraceno. Se presentó el primer caso de melanosis coli diagnosticado en los últimos 30 años de trabajo, en el departamento de Gastroenterología del Hospital Faustino Pérez, de Matanzas. Se trata de un paciente con antecedentes de estreñimiento crónico, al cual se le diagnóstica esta entidad por estudio videoendoscópico del colon, corroborándose por estudio histológico, concluyéndose que esta entidad constituye una condición inocua que no traduce manifestaciones clínicas. Casi siempre, aparece de forma accidental en pacientes a los que se les realiza estudios endoscópicos del tracto digestivo inferior y con historia de abuso de laxantes. Para evitarla se recomienda régimen higiénico dietético adecuado, consumo de alimentos ricos en fibras, ejercicios físicos sistemáticos y proscribiendo el uso de laxantes derivados de las antroquinonas. Por tanto, es de gran importancia para Gastroenterólogos estar conscientes de su existencia. A pesar, de que no esté dilucidada todavía la importancia clínica de esta entidad(AU)


The Melanosis coli consist in a blackish pigmentation of the large intestine mucosa, produced for the absorption of aromatic products due to the excessive usage of anthracene-derived laxatives. We present the first case of Melanosis coli diagnosed in the Gastroenterology Department of the Hospital Faustino Perez, of Matanzas in the last 30 years. It is the case of a patient with antecedents of chronic constipation, to whom the disease is diagnosed as a result of a colon videoendoscopic study, corroborated by histological study, concluding that this disease is an innocuous condition without clinical manifestations. It almost always appears in an accidental way, in patients to whom endoscopic studies of the low digestive tract are carried out, and having a history of laxatives abuse. To avoid it, an adequate hygiene-epidemiologic regime, rich-in-fibers food consumption, systemic physical training and the proscription of anthraquinone-derived laxatives are need. It is very importance for the gastroenterologists to be conscious of the existence of this entity, although its clinical importance is not elucidated yet(AU)


Subject(s)
Humans , Male , Aged , Melanosis/diagnosis , Melanosis/prevention & control , Melanosis/therapy , Endoscopy, Gastrointestinal/methods , Intestine, Large/physiopathology , Case Reports
18.
Expert Rev Gastroenterol Hepatol ; 9(11): 1351-8, 2015.
Article in English | MEDLINE | ID: mdl-26488223

ABSTRACT

Transient ileus is a normal physiologic process after surgery. When prolonged, it is an important contributor to postoperative complications, increased length of stay and increased healthcare costs. Efforts have been made to prevent and manage postoperative ileus; alvimopan is an oral, peripheral µ-opioid receptor antagonist, and the only currently US FDA-approved medication to accelerate the return of gastrointestinal function postoperatively.


Subject(s)
Digestive System Surgical Procedures/adverse effects , Gastrointestinal Agents/therapeutic use , Ileus/drug therapy , Intestine, Large/drug effects , Intestine, Large/surgery , Intestine, Small/drug effects , Intestine, Small/surgery , Narcotic Antagonists/therapeutic use , Piperidines/therapeutic use , Administration, Oral , Gastrointestinal Agents/administration & dosage , Gastrointestinal Agents/adverse effects , Humans , Ileus/etiology , Ileus/metabolism , Ileus/physiopathology , Intestine, Large/metabolism , Intestine, Large/physiopathology , Intestine, Small/metabolism , Intestine, Small/physiopathology , Narcotic Antagonists/administration & dosage , Narcotic Antagonists/adverse effects , Piperidines/administration & dosage , Piperidines/adverse effects , Receptors, Opioid, mu/antagonists & inhibitors , Receptors, Opioid, mu/metabolism , Recovery of Function , Risk Factors , Treatment Outcome
19.
Ultraschall Med ; 36(3): 216-35; quiz 236-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25905814

ABSTRACT

Learning objectives: Sonographic examination concept in the case of suspicion of bowel obstruction. Recognition of the sonographic criteria of a bowel obstruction. Ability to detect the level of a bowel obstruction. Sonographic detection of typical causes of bowel obstruction. Detection of sonographic signs of complicated bowel obstruction. Ability to sonographically define important differential diagnoses. Further diagnostic procedures in unclear situations.


Subject(s)
Intestinal Obstruction/diagnostic imaging , Diagnosis, Differential , Humans , Intestinal Obstruction/etiology , Intestinal Obstruction/physiopathology , Intestinal Obstruction/surgery , Intestine, Large/diagnostic imaging , Intestine, Large/physiopathology , Intestine, Small/diagnostic imaging , Intestine, Small/physiopathology , Postoperative Complications/diagnostic imaging , Risk Factors , Sensitivity and Specificity , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...